New Research Hints at Potential Neuroprotective Properties of GLP-1 Receptor Agonists Beyond Glycemic Control
Emerging scientific inquiry suggests a compelling correlation between the utilization of glucagon-like peptide-1 (GLP-1) receptor agonists and a diminished likelihood of developing epilepsy. This...
